Related Experiment Videos
The cell biology of antigen processing and presentation
1Department of Pharmacy, University of California, School of Pharmacy, San Francisco 94143.
Annual Review of Immunology
|January 1, 1991
Summary
Histocompatibility molecules like MHC class I and II present peptides to T cells. Their distinct intracellular pathways and peptide sources influence antigen presentation and vaccine design.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Histocompatibility molecules (MHC class I and II) present antigenic peptides to T cells.
- Despite structural similarities, MHC class I and II molecules present peptides from different intracellular locations and antigen sources.
- MHC class I presents endogenous peptides, while MHC class II presents both exogenous and endogenous peptides.
Purpose of the Study:
- To elucidate the distinct intracellular trafficking and peptide-binding mechanisms of MHC class I and II molecules.
- To understand how antigen processing and cellular location influence presentation by MHC class I versus MHC class II.
- To inform vaccine design by considering the factors governing antigen presentation pathways.
Main Methods:
- The study focuses on the assembly, intracellular trafficking, and endocytosis processes involved in antigen presentation.
- Key mechanisms discussed include the role of the invariant chain in MHC class II function.
- Analysis of peptide acquisition by MHC class I versus MHC class II molecules.
Main Results:
- MHC class I peptide acquisition is primarily dependent on molecular assembly.
- MHC class II antigen presentation is influenced by assembly, trafficking, and endocytosis.
- The invariant chain is crucial for MHC class II endosomal targeting and peptide-binding competence.
Conclusions:
- The intracellular origin and processing of antigens significantly determine their presentation by MHC class I or class II.
- Understanding these distinct pathways is critical for effective vaccine development.
- The differential mechanisms of MHC class I and II antigen presentation offer targets for immunomodulation.